drugset / Trial / NCT01677377
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
Non-randomizedFactorialOpen-labelTreatment
Summary
Evaluate the safety and tolerability of multiple subcutaneous injections of various dosages of risperidone with clinically stable schizophrenia
Timeline
- Start
- 2012-08
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 60 mg | Subcutaneous |
| Subject | Risperidone | Other / unclassified | 90 mg | Subcutaneous |
| Subject | Risperidone | Other / unclassified | 120 mg | Subcutaneous |
| Subject | Risperidone | Other / unclassified | 2 mg | Oral |
| Subject | Risperidone | Other / unclassified | 3 mg | Oral |
| Subject | Risperidone | Other / unclassified | 4 mg | Oral |